Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,798 | 17,129 | 75,618 | 105,033 | 8,438 |
| Marketable Securities | 2,548 | 36,708 | 18,858 | 10,840 | 83,144 |
| Receivables | 97 | 570 | 2,493 | 1,026 | 3,236 |
| Inventories | 290 | N/A | N/A | 920 | 1,008 |
| Other current assets | 0 | 0 | 0 | 0 | 3,500 |
| TOTAL | $22,637 | $64,538 | $107,076 | $127,932 | $105,419 |
| Non-Current Assets | |||||
| PPE Net | 6,025 | 7,915 | 12,278 | 22,360 | 11,341 |
| Intangibles | 33,021 | 18,727 | 19,303 | 21,239 | 18,399 |
| Other Non-Current Assets | 11,830 | 10,641 | 16,783 | 13,465 | 10,931 |
| TOTAL | $50,876 | $37,283 | $48,364 | $57,064 | $40,671 |
| Total Assets | $73,513 | $101,821 | $155,440 | $184,996 | $146,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,837 | 2,816 | 9,780 | 1,382 | 1,766 |
| Accounts payable and accrued liabilities | 6,595 | 639 | 3,370 | 7,309 | 4,031 |
| Accrued Expenses | 26,034 | 28,567 | 17,558 | 25,020 | 26,959 |
| Other current liabilities | N/A | 2,270 | N/A | N/A | N/A |
| TOTAL | $53,546 | $34,372 | $30,788 | $34,119 | $33,521 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,879 | 4,667 | 7,326 | 30,176 | 3,702 |
| Deferred Revenues | 80 | 80 | 80 | 408 | 765 |
| Other Non-Current Liabilities | 117,657 | 163,908 | 223,865 | 190,099 | 190,099 |
| TOTAL | $127,856 | $169,053 | $231,749 | $221,585 | $195,111 |
| Total Liabilities | $181,402 | $203,425 | $262,537 | $255,704 | $228,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32 | 13 | 8 | 5 | 4 |
| Common Shares | 979,295 | 860,691 | 721,544 | 652,773 | 394,750 |
| Retained earnings | -1,109,413 | -961,108 | -825,289 | -722,784 | -470,486 |
| Other shareholders' equity | 22,229 | -1,187 | -3,352 | -697 | -6,806 |
| TOTAL | $-107,889 | $-101,604 | $-107,097 | $-70,708 | $-82,542 |
| Total Liabilities And Equity | $73,513 | $101,821 | $155,440 | $184,996 | $146,090 |